Synonyms: Anti-GIF; Anti-GIFB; Anti-Growth inhibitory factor; Anti-MT-3; Anti-MT-III; Anti-Metallothionein-3; Anti-Metallothionein-III
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: Metallothionein 3 (MT3) is regulated in the non-amyloidogenic pathway to generate soluble APPa (sAPPa). It increases the activity of ADAM10. This gene possesses cell growth inhibitory activity and its upregulation can inhibit esophageal cancer cell proliferation and induce apoptosis, which may be achieved by blocking the tumor cell growth cycle. It is an androgen-upregulated gene that promotes tumorigenesis of prostate carcinoma cells. It expression may have an impact on the pathogenesis of NSCLC. It is highly expressed in the normal human brain and is down-regulated in Alzheimer disease.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC